FC2Video

http://www.taipanfinancialnews.com -- This stock is already up 106% and has room for more growth. It is the only
company in its industry posting sold numbers. Plus, Erin Beale reveals the details on another company that is a fantastic buy at under $12. Two of its top drugs are in Phase II FDA trials. If the integrated link within the video doesn't work on this viewer, click on this link or paste it into your browser: http://www.isecureonline.com/reports/DEN/WDENH308/